Skip to main content
Clinical Trials/NCT03102346
NCT03102346UnknownNot Applicable

A Perspective Randomized Controlled Clinical Trial to Investigate the Effect of Home-based Cardiac Rehabilitation Monitored by Mobile Phone Interaction on Exercise Capacity and One-year Clinical Outcome in Chinese Revascularized Patients

Chinese PLA General Hospital1 site in 1 country2,000 target enrollmentStarted: November 9, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
2,000
Locations
1
Primary Endpoint
MACCE(death, nonfatal myocardial infarction, revascularization, stroke)

Study Overview

Brief Summary

Home-based CR (HBCR) was reported to improve the clinical outcomes of coronary artery disease (CAD) patients. There is no data published to investigate whether HBCR is also effective for Chinese CAD patients who have been revascularized.

This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI (Percutaneous Coronary Intervention) procedure. This is a multicenter, randomized, controlled and observational study.

Detailed Description

Numerous studies have revealed that cardiac rehabilitation (CR) after myocardial Cardiac rehabilitation (CR) after revascularization results in better clinical outcomes, and have been strongly recommended for patients with coronary artery disease. In China, as compared to the exponential increase of PCI (Percutaneous Coronary Intervention) volume, only a very small amount of hospitals are able to develop CR programs. There is no large-scale study to explore the feasible CR pattern either. Home-based CR might be more favorable and practical for so many Chinese revascularized coronary artery disease (CAD) patients due to its feasibility and flexibility as well as low medical cost.

This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI procedure. This is a multicenter, randomized, controlled and observational study. The efficacy and safety of Home-based CR (HBCR) in revascularized patients will be evaluated through observation of its clinical characteristics and safety indicators. The study will involve 14 sites nationwide, with an expected sample size of 2,000 followed up for 12 months. The primary endpoints is the incidence of composite major adverse cardiac and cerebrovascular events (MACCE,death from any cause, nonfatal myocardial infarction, revascularization, stroke).Secondary endpoints are defined as decrease of hospitalization due to refractory angina pectoris,the improvements of cardiorespiratory fitness,life quality,as well as angina pectoris.

The subjects will be randomized into 2 different groups, HBCR group and control group. After comprehensive evaluation, the orders from CR staff will be given. Besides the routine health education in both groups, the subjects in HBCR group will be further introduced the instructions of exercise training. The effect of HBCR on cardiorespiratory fitness, improvement of angina, cardiac function, quality of life, levels of anxiety and depression, as well as risk factor profile will also be evaluated. The investigators also aim to explore the factors which influence the adherence of subjects to our HBCR program.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
30 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all of them
  • age range from 30 to
  • coronary artery disease,revascularized with stent deployment.
  • New York Heart Association (NYHA) classification Class I-III.
  • Good cognitive level.
  • Ability to perform aerobic exercise.
  • Understand be able to use a mobile smart phone by himself or with help of family members.
  • Signature of informed consent. The informed consent will be valid for the duration of the trial or until the subject withdraws.

Exclusion Criteria

  • (Enrollment):
  • Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled.
  • Hypotensive response to exercise.
  • acute myocardial infarction within 2 weeks
  • Poorly controlled hypertension baseline,hyperglycemia,respiratory failure.
  • severe pulmonary hypertension
  • acute phase of heart failure
  • Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation.
  • Pregnant women.
  • Subjects unable to give informed consent.

Arms & Interventions

Home-based Cardiac Rehabilitation group

Experimental

remote instructed exercise training at home

Intervention: home-based cardiac rehabilitation (Other)

routine group

No Intervention

no instructed exercise training

Outcomes

Primary Outcomes

MACCE(death, nonfatal myocardial infarction, revascularization, stroke)

Time Frame: during 12 months

defined as the incidence of composite MACCE.

Secondary Outcomes

  • improvement of hospitalization due to refractory angina pectoris(during 12 months)
  • improvement of cardiorespiratory fitness(during 12 months)
  • improvement of angina pectoris(during 12 months)
  • improvement of life quality(during 12 months)

Investigators

Sponsor
Chinese PLA General Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yun Dai Chen

Director, Head of Cardiology, Principal Investigator, Clinical Professor

Chinese PLA General Hospital

Study Sites (1)

Loading locations...

Similar Trials